578 related articles for article (PubMed ID: 29437615)
21. Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.
González GM; Tijerina R; Najvar LK; Bocanegra R; Luther M; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 2001 Jun; 45(6):1854-9. PubMed ID: 11353637
[TBL] [Abstract][Full Text] [Related]
22. Comparative efficacies of terbinafine and fluconazole in treatment of experimental coccidioidal meningitis in a rabbit model.
Sorensen KN; Sobel RA; Clemons KV; Calderon L; Howell KJ; Irani PR; Pappagianis D; Williams PL; Stevens DA
Antimicrob Agents Chemother; 2000 Nov; 44(11):3087-91. PubMed ID: 11036027
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo activities of posaconazole against Coccidioides immitis.
González GM; Tijerina R; Najvar LK; Bocanegra R; Rinaldi M; Loebenberg D; Graybill JR
Antimicrob Agents Chemother; 2002 May; 46(5):1352-6. PubMed ID: 11959568
[TBL] [Abstract][Full Text] [Related]
24. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility of TLR4-defective C3H/HeJ mice to Coccidioides posadasii infection.
Awasthi S
Med Mycol; 2010 May; 48(3):470-5. PubMed ID: 20370361
[TBL] [Abstract][Full Text] [Related]
26. The mysterious desert dwellers: Coccidioides immitis and Coccidioides posadasii, causative fungal agents of coccidioidomycosis.
Kollath DR; Miller KJ; Barker BM
Virulence; 2019 Dec; 10(1):222-233. PubMed ID: 30898028
[TBL] [Abstract][Full Text] [Related]
27. Coccidioides posadasii infection alters the expression of pulmonary surfactant proteins (SP)-A and SP-D.
Awasthi S; Magee DM; Coalson JJ
Respir Res; 2004 Dec; 5(1):28. PubMed ID: 15588319
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the susceptibility of Coccidioides immitis to lufenuron, a chitin synthase inhibitor.
Johnson SM; Zimmermann CR; Kerekes KM; Davidson A; Pappagianis D
Med Mycol; 1999 Dec; 37(6):441-4. PubMed ID: 10647126
[TBL] [Abstract][Full Text] [Related]
29.
Wiederhold NP; Xu X; Wang A; Najvar LK; Garvey EP; Ottinger EA; Alimardanov A; Cradock J; Behnke M; Hoekstra WJ; Brand SR; Schotzinger RJ; Jaramillo R; Olivo M; Kirkpatrick WR; Patterson TF
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104280
[TBL] [Abstract][Full Text] [Related]
30. Host-Pathogen Interactions in Coccidioidomycosis: Prognostic Clues and Opportunities for Novel Therapies.
Krogstad P; Johnson R; Garcia-Lloret MI; Heidari A; Butte MJ
Clin Ther; 2019 Oct; 41(10):1939-1954.e1. PubMed ID: 31648806
[TBL] [Abstract][Full Text] [Related]
31. In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil.
Cordeiro RA; Brilhante RS; Rocha MF; Fechine MA; Costa AK; Camargo ZP; Sidrim JJ
Mycopathologia; 2006 Jan; 161(1):21-6. PubMed ID: 16389480
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro antifungal activity of isoniazid-derived hydrazones against Coccidioides posadasii.
Cordeiro Rde A; de Melo CV; Marques FJ; Serpa R; Evangelista AJ; Caetano EP; Mafezoli J; de Oliveira Mda C; da Silva MR; Bandeira Tde J; Moreira JL; Brilhante RS; Rocha MF; Sidrim JJ
Microb Pathog; 2016 Sep; 98():1-5. PubMed ID: 27334293
[TBL] [Abstract][Full Text] [Related]
33. Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis.
Thompson GR; Lunetta JM; Johnson SM; Taylor S; Bays D; Cohen SH; Pappagianis D
Clin Infect Dis; 2011 Sep; 53(6):e20-4. PubMed ID: 21865185
[TBL] [Abstract][Full Text] [Related]
34. Efficacies of two novel azole derivatives each containing a morpholine ring, UR-9746 and UR-9751, against systemic murine coccidioidomycosis.
Clemons KV; Stevens DA
Antimicrob Agents Chemother; 1997 Jan; 41(1):200-3. PubMed ID: 8980782
[TBL] [Abstract][Full Text] [Related]
35. Selection of Specific Peptides for
Duarte Escalante E; Frías De León MG; Martínez García LG; Herrera J; Acosta Altamirano G; Cabello C; Palma G; Reyes Montes MDR
Molecules; 2018 Nov; 23(12):. PubMed ID: 30513599
[TBL] [Abstract][Full Text] [Related]
36. Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis.
Lutz JE; Clemons KV; Aristizabal BH; Stevens DA
Antimicrob Agents Chemother; 1997 Jul; 41(7):1558-61. PubMed ID: 9210684
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary coccidioidomycosis.
Thompson GR
Semin Respir Crit Care Med; 2011 Dec; 32(6):754-63. PubMed ID: 22167403
[TBL] [Abstract][Full Text] [Related]
38. Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis.
Sorensen KN; Sobel RA; Clemons KV; Pappagianis D; Stevens DA; Williams PL
Antimicrob Agents Chemother; 2000 Jun; 44(6):1512-7. PubMed ID: 10817701
[TBL] [Abstract][Full Text] [Related]
39. Detection of Coccidioides posadasii from xerophytic environments in Venezuela reveals risk of naturally acquired coccidioidomycosis infections.
Alvarado P; Teixeira MM; Andrews L; Fernandez A; Santander G; Doyle A; Perez M; Yegres F; Barker BM
Emerg Microbes Infect; 2018 Mar; 7(1):46. PubMed ID: 29593263
[TBL] [Abstract][Full Text] [Related]
40. Coccidioidomycosis: first cases reported in Pernambuco, Brazil.
Araújo PSR; Souza Junior VR; Padilha CE; Oliveira MI; Arraes LC; Vieira R; Antunes A; Lima Neto RG; Marsden A
Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e75. PubMed ID: 30462798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
